Sign In
NewsRadar

The Genetics Company

The Genetics Company is a dedicated team of entrepreneurs and scientists focusing on the research, development and commercialization of products for cancer therapy. It has developed a worldwide leadership position in the understanding of Wnt-signaling, a physiological process believed to playing a crucial role in the pathogenesis of colorectal and other cancer.

• Show past press releases
• Edit this company

Elevator Pitch
The Company has identified small molecule Wnt-inhibitors and several proprietary drug targets within the Wnt-pathway. It also owns a portfolio of assets for the diagnosis and therapy of Alzheimer's disease, comprising small molecule inhibitors of beta-secretase (BACE) and a set of diagnostic kits and tools for the diagnosis and monitoring of patients suffering from Alzheimer's disease, as well as for research purposes.

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Wagistrasse 27
Schlieren 8952
Switzerland
+41 (0)44 2002 200
+41 (0)44 2002 211
http://www.the-genetics.com
Harald Eistetter
+41 (0)44 2002 200

Company Facts
Founded:May 1998
Founders:Dr. Michel Aguet, Dr. Ernst Hafen, Mario Jenni, Dr. Konrad Basler
CEO:Dr. Harald Eistetter
CTO or technical lead:
CFO or finance director:Andreas Ziegler
Head of Sales:Dr. Sebastian Breuer
Head of Marketing:Victoria Gibson

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Biotechnology
Employees:28
Profitability:Not Profitable
Funding raised:Yes
Funding sought:No
Seeking Partnerships:Yes

Non-executive Board Members

  • Dr. Alfred Scheidegger, Founder Nextech Venture LLP, Nextech Venture AG
  • Hans-Beat Gürtler, Varuma AG
  • Dr. Rudolf Gygax, Managing Director, Novartis Venture Fund
  • Dr. Peter Rickli, Partner, Christen Rickli Partner

    Key Customers

  • Neurochem Inc., Montréal, Canada
  • JSW Research GmbH, Graz, Austria
  • Roche AG, Basel, Switzerland
  • University of Leuven, Belgium
  • Univeristy Hospital Erlangen, Germany

    Key Business Partners

  • Morphochem AG, Basel/Munich

    Key Competitors

    Capital Raised
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    DateTypeExchange
    No public offerings


  • Data


    26,807
    Tech investments
    From our Online Data Service
    17,301
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Nov 25€24.0MInternet commerce
    Mar 23€2.0MInternet services
    Mar 23€1.5MInternet services
    Mar 23€110.0MInternet commerce
    Mar 21€1.9MBusiness applications
    Mar 20€1.0MInternet commerce
    Mar 20€12.0ME-Commerce

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    May 28
    Identiq
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    Nethone
    nethone raised over $1 million from innovation nest

    Jan 29
    Yumpingo
    yumpingo raises $10m to transform guest experiences in restaurants

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase





    About usContact usLegal Information
    Copyright 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.